According to Baiyang Pharmaceutical's announcement, the company recently received a letter from the controlling shareholder Baiyang Pharmaceutical Group Co., Ltd. to learn that its 6,771,768 shares of the company have been released from the pledge, accounting for 1.92% of the company's total share capital and 1.29% of the shares it holds. The pledge holder is Daye Trust Co., Ltd. As of the disclosure date of the announcement, the controlling shareholders and their co-actors held a total of 390,957,310 shares of the company, accounting for 74.38% of the total share capital; they pledged a cumulative total of 185,220,613 shares, accounting for 47.38% of their shares and 35.24% of the company's total share capital. The shares held were not frozen or auctioned, and there was no risk of closing the pledged shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.